⌘K

Login Start Free

Home/Filings/4/0002064832-25-000042

4//SEC Filing

Luly Jay R. 4

Accession 0002064832-25-000042

CIK 0001177648other

View on SEC.gov Company Profile

Filed

Dec 2, 7:00 PM ET

Accepted

Dec 3, 4:34 PM ET

Size

4.7 KB

Accession

0002064832-25-000042

Insider Transaction Report

Form 4

Period: 2025-12-01

ENANTA PHARMACEUTICALS INCENTA

DirectorPresident and CEO

Transactions

Tax Payment
Common Stock
2025-12-01$14.12/sh−1,885$26,616→ 862,769 total

Footnotes (1)

[F1]Represents the number of shares of ENTA common stock forfeited by the reporting person to cover withholding taxes due as a result of settlement of a portion of the restricted stock unit award granted on November 19, 2021.

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

ENANTA PHARMACEUTICALS INC

CIK 0001177648

Entity typeother

Related Parties

1

filerCIK 0001571211

Filing Metadata

Form type: 4
Filed: Dec 2, 7:00 PM ET
Accepted: Dec 3, 4:34 PM ET
Size: 4.7 KB

View on SEC.gov